Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer
5 clinical trials · Condition
◉ Watch Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer
| Record | Firm | Date |
|---|---|---|
| A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer. (NCT03504397) | Astellas Pharma Global Development, Inc. | 2018-06-21 |
| Early Access Program for Zolbetuximab (NCT06048081) | Astellas Pharma Global Development, Inc. |
Track Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer automatically
Every clearance here is in the API, with alerts when new ones post.